Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 813

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study

Open access
Cariou, Bertrand, Hadjadj, Samy, Wargny, Matthieu, Pichelin, Matthieu, Al-Salameh, Abdallah, Allix, Ingrid, Amadou, Coralie, Arnault, Gwénaëlle, Baudoux, Florence, Bauduceau, Bernard, Borot, Sophie, Bourgeon-Ghittori, Muriel, Bourron, Olivier, Boutoille, David, Cazenave-Roblot, France, Chaumeil, Claude, Cosson, Emmanuel, Coudol, Sandrine, Darmon, Patrice, Disse, Emmanuel, Ducet-Boiffard, Amélie, Gaborit, Bénédicte, Joubert, Michael, Kerlan, Véronique, Laviolle, Bruno, Marchand, Lucien, Meyer, Laurent, Potier, Louis, Prevost, Gaëtan, Riveline, Jean-Pierre, Robert, René, Saulnier, Pierre-Jean, Sultan, Ariane, Thébaut, Jean-François, Thivolet, Charles, Tramunt, Blandine, Vatier, Camille, Roussel, Ronan, Gautier, Jean-François, Gourdy, Pierre, for the CORONADO investigators·2020·Diabetologia

Abstract

Aims/hypothesis: Coronavirus disease-2019 (COVID-19) is a life-threatening infection caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) virus. Diabetes has rapidly emerged as a major comorbidity for COVID-19 severity. However, the phenotypic characteristics of diabetes in COVID-19 patients are unknown. Methods: We conducted a nationwide multicentre observational study in people with diabetes hospitalised for COVID-19 in 53 French centres in the period 10–31 March 2020. The primary outcome combined tracheal intubation for mechanical ventilation and/or death within 7 days of admission. Age- and sex-adjusted multivariable logistic regressions were performed to assess the prognostic value of clinical and biological features with the endpoint. ORs are reported for a 1 SD increase after standardisation. Results: The current analysis focused on 1317 participants: 64.9% men, mean age 69.8 ± 13.0 years, median BMI 28.4 (25th–75th percentile: 25.0–32.7) kg/m 2; with a predominance of type 2 diabetes (88.5%). Microvascular and macrovascular diabetic complications were found in 46.8% and 40.8% of cases, respectively. The primary outcome was encountered in 29.0% (95% CI 26.6, 31.5) of participants, while 10.6% (9.0, 12.4) died and 18.0% (16.0, 20.2) were discharged on day 7. In univariate analysis, characteristics prior to admission significantly associated with the primary outcome were sex, BMI and previous treatment with renin–angiotensin–aldosterone system (RAAS) blockers, but not age, type of diabetes, HbA 1c, diabetic complications or glucose-lowering therapies. In multivariable analyses with covariates prior to admission, only BMI remained positively associated with the primary outcome (OR 1.28 [1.10, 1.47]). On admission, dyspnoea (OR 2.10 [1.31, 3.35]), as well as lymphocyte count (OR 0.67 [0.50, 0.88]), C-reactive protein (OR 1.93 [1.43, 2.59]) and AST (OR 2.23 [1.70, 2.93]) levels were independent predictors of the primary outcome. Finally, age (OR 2.48 [1.74, 3.53]), treated obstructive sleep apnoea (OR 2.80 [1.46, 5.38]), and microvascular (OR 2.14 [1.16, 3.94]) and macrovascular complications (OR 2.54 [1.44, 4.50]) were independently associated with the risk of death on day 7. Conclusions/interpretations: In people with diabetes hospitalised for COVID-19, BMI, but not long-term glucose control, was positively and independently associated with tracheal intubation and/or death within 7 days. Trial registration: clinicaltrials.gov NCT04324736.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00125-020-05180-x

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 25 references

Cited by

See all 813

Metadata

Authors
Cariou, B., Hadjadj, S., Wargny, M., Pichelin, M., Al-Salameh, A., Allix, I., Amadou, C., Arnault, G., Baudoux, F., Bauduceau, B., Borot, S., Bourgeon-Ghittori, M., Bourron, O., Boutoille, D., Cazenave-Roblot, F., Chaumeil, C., Cosson, E., Coudol, S., Darmon, P., Disse, E., Ducet-Boiffard, A., Gaborit, B., Joubert, M., Kerlan, V., Laviolle, B., Marchand, L., Meyer, L., Potier, L., Prevost, G., Riveline, J.-P., Robert, R., Saulnier, P.-J., Sultan, A., Thébaut, J.-F., Thivolet, C., Tramunt, B., Vatier, C., Roussel, R., Gautier, J.-F., Gourdy, P., & for the CORONADO investigators
Venue
Diabetologia
Published
2020-05-29
Volume
63
Issue
8
Pages
1500-1515
ISSN
  • 0012-186X (ISSN-L)
  • 1432-0428
OpenAlex
W3031959493
Cited by
813
References
25
FWCI
22.09
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study. https://app.cochat.ai/papers/10.1007/s00125-020-05180-x
The paper
Cariou, B., Hadjadj, S., Wargny, M., Pichelin, M., Al-Salameh, A., Allix, I., Amadou, C., Arnault, G., Baudoux, F., Bauduceau, B., Borot, S., Bourgeon-Ghittori, M., Bourron, O., Boutoille, D., Cazenave-Roblot, F., Chaumeil, C., Cosson, E., Coudol, S., Darmon, P., . . . for the CORONADO investigators. (2020). Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study. Diabetologia. https://doi.org/10.1007/s00125-020-05180-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.